ea0079008 | Abstracts | BES2021
Lisa Billion
, Sara Charleer
, Laurens Verbraeken
, Mira Sterckx
, Kato Vangelabbeek
, Block Nathalie De
, Charlien Janssen
, Dessel Kristof Van
, Eveline Dirinck
, Frida Peiffer
, Nancy Bolsens
, Chantal Mathieu
, Pieter Gillard
, Christophe De Block
Background and Aims: To evaluate whether switching from traditional mealtime insulin analogs to fast-acting insulin aspart (Fiasp) in routine clinical practice is efficacious and safe in adult people with type 1 diabetes (PWD1) using intermittent or real-time continuous glucose monitoring (iCGM or rtCGM).Methods: Data from 438 adult PWD1 (60% men, age 44.6±16.1 years, duration of diabetes 21.5±14.0 years, iCGM/rtCGM: 391/47, injections/pump: 409/29...